Update on Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA‐ALCL)

Women who are concerned about their breast implants following reports of a study linking infection caused by implants to a rare cancer, anaplastic large cell lymphoma (ALCL), should discuss their concerns with their doctor.

The Therapeutic Goods Authority continues not to recommend preventative breast implant removal in patients without symptoms or other abnormality.

ASPS is developing a national register of member surgeons who are willing to see concerned women with symptoms and assess their implants for no out-of-pocket expense consultation. The patients first option should be to see the surgeon who put the implants in but if they can't or don't want to, then members on the register will see the patient for an assessment with a referral from their GP.

This initial consultation is an opportunity to discuss concerns. If the patient chooses to undertake further investigation or commit to a procedure, subsequent costs may be incurred.

The register can be accessed here


Related information:


Update – additional confirmed cases of anaplastic large cell lymphoma,  20 April 2017

ASPS Guide for Patients ALCL, Updated 16 July 2016

ASPS Media Release, 11 November 2014

For the Record, Herald Sun correction, 12 November 2014

For the Record, Adelaide Advertiser correction, 12 November 2014

For the Record, Daily Telegraph correction, 12 November 2014

Breast Cancer Network Australia, 11 November 2014

Safety Information, Therapeutic Goods Administration.

Categories relating to this article include:
Breast Implants

Share this: